ISDA

Entry Detail

PDB ID:

6VNV

Keywords:

TRANSFERASE/INHIBITOR

Title:

Crystal structure of TYK2 kinase with compound 14

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Spodoptera frugiperda

PDB Version:

Deposition Date:

2020-01-29

Release Date:

2020-04-08

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.15 Å

R-Value Free:

0.23

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Non-receptor tyrosine-protein kinase TYK2
Mutations:C936A, C1142A, Q969A, E971A, K972A
Chain IDs:A
Chain Length:318
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P29597 Pfam ID:PF07714 EC:2.7.10.2

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	A	TYR	modified residue

Ligand Molecules

R4Y

Primary Citation

Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1.

Fensome, A, Ambler, C.M, Arnold, E, Banker, M.E, Clark, J.D, Dowty, M.E, Efremov, I.V, Flick, A, Gerstenberger, B.S, Gifford, R.S, Gopalsamy, A, Hegen, M, Jussif, J, Limburg, D.C, Lin, T.H, Pierce, B.S, Sharma, R, Trujillo, J.I, Vajdos, F.F, Vincent, F, Wan, Z.K, Xing, L, Yang, X, Yang, X.Show

Bioorg.Med.Chem. 28 115481 115481 (2020)

PMID: 32253095 DOI: 10.1016/j.bmc.2020.115481

Abstact

Herein, we disclose a new series of TYK2/ JAK1 inhibitors based upon a 3.1.0 azabicyclic substituted pyrimidine scaffold. We illustrate the use of structure-based drug design for the initial design and subsequent optimization of this series of compounds. One advanced example 19 met program objectives for potency, selectivity and ADME, and demonstrated oral activity in the adjuvant-induced arthritis rat model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures